Quantitative RNA Analysis from Urine Using Real Time PCR

  • Lourdes MengualEmail author
  • Mireia Olivan
Part of the Methods in Molecular Biology book series (MIMB, volume 1655)


Urine is emerging as a biological fluid suitable to perform liquid biopsy in a minimally invasive manner, a fundamental attribute for prevention and early detection of cancer. Urine biomarkers can be analyzed in voided urine, in urine sediment, and urine supernatant. In the case of urothelial carcinoma, in which tumor cells are in direct contact with urine, the assessment of the levels of biomarkers in the urinary cell fraction appears to be the most promising approach to identify diagnostic and prognostic biomarkers in a noninvasive way. Here, we describe a protocol to collect and process urine samples to obtain urinary exfoliated cells. Furthermore, we describe the methodology to isolate RNA from urinary cells and to quantify gene expression levels from these urinary cells.

Key words

cDNA pre-amplification Gene expression Quantitative PCR Reverse transcription RNA Urine 


  1. 1.
    Pisitkun T, Johnstone R, Knepper MA (2006) Discovery of urinary biomarkers. Mol Cell Proteomics 5:1760–1771CrossRefPubMedGoogle Scholar
  2. 2.
    Rigau M, Olivan M, Garcia M et al (2013) The present and future of prostate cancer urine biomarkers. Int J Mol Sci 14:12620–12649CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Decramer S, Gonzalez DP, Breuil B et al (2008) Urine in clinical proteomics. Mol Cell Proteomics 7:1850–1862CrossRefPubMedGoogle Scholar
  4. 4.
    Wu J, Chen YD, Gu W (2010) Urinary proteomics as a novel tool for biomarker discovery in kidney diseases. J Zhejiang Univ Sci B 11:227–237CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Rigau M, Ortega I, Mir MC et al (2011) A three-gene panel on urine increases PSA specificity in the detection of prostate cancer. Prostate 71:1736–1745CrossRefPubMedGoogle Scholar
  6. 6.
    Mengual L, Burset M, Ribal MJ et al (2010) Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res 16:2624–2633CrossRefPubMedGoogle Scholar
  7. 7.
    Mengual L, Ribal MJ, Lozano JJ et al (2014) Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. J Urol 191:261–269CrossRefPubMedGoogle Scholar
  8. 8.
    Ribal MJ, Mengual L, Lozano JJ et al (2016) Gene expression test for the non-invasive diagnosis of bladder cancer: a prospective, blinded, international and multicenter validation study. Eur J Cancer 54:131–138CrossRefPubMedGoogle Scholar
  9. 9.
    Huebner AR, Somparn P, Benjachat T et al (2015) Exosomes in urine biomarker discovery. Adv Exp Med Biol 845:43–58CrossRefPubMedGoogle Scholar
  10. 10.
    Chomczynski P, Mackey K (1995) Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19:942–945PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Laboratory and Department of Urology, Centre de Recerca Biomèdica CELLEX, Hospital Clínic, Universitat de BarcelonaIDIBAPSBarcelonaEspaña
  2. 2.Group of Biomedical Research in Urology, Vall d’Hebron Research Institute (VHIR)Universitat Autònoma de Barcelona (UAB)BarcelonaSpain

Personalised recommendations